Surgery – Blood drawn and replaced or treated and returned to body
Patent
1992-09-24
1994-01-18
Hafer, Robert A.
Surgery
Blood drawn and replaced or treated and returned to body
604 5, A61M 3700
Patent
active
052795403
ABSTRACT:
A method for reducing the risk of atherosclerosis in a patient at risk of same comprising the steps of removing cholesterol ester transfer protein from blood of the patient to reduce the plasma CETP levels in the patient. In an embodiment, the method includes the step of passing the patient's plasma through an apheresis machine to remove at least some of the plasma cholesterol ester transfer protein.
REFERENCES:
patent: 4605394 (1986-08-01), Shurkovich
patent: 4692411 (1987-09-01), Ghose
patent: 4923439 (1990-05-01), Seidel et al.
"Plasma High Density Lipoprotein is Increased in Man when LDL is Lowered by LDL Pheresis" Parker et al., Proceedings, Natl. Academy of Sciences, vol. 83, pp. 777-781, Feb. 1986.
Brown et al, Molecular Basis of Lipid Transfer Protein Deficiency in a Family with Increased High-Density Lipoproteins, Nature, vol. 342, Nov. 23, 1989.
Barter, Enzymes Involved in Lipid and Lipoprotein Metabolism, Current Opinion in Lipidology 1990, 1:518-523.
Cholesteryl Ester Transfer Protein, The Lancet, vol. 338: Sep. 14, 1991.
Inazu et al, Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation, The New England Journal of Medicine, vol. 323, No. 18, pp. 1234-1238.
Yamashita et al, Accumulation of Apolipoprotein E-rich High Density Lipoproteins in Hyperalphalipoproteinemic Human Subjects with Plasma Cholesteryl Ester Transfer Protein Deficiency, J. Clin. Invest., vol. 86, 9-90, 688-695.
Hesler et al, Structure-Function Analysis of Plasma Cholesteryl Ester Transfer Protein by Protease Digestion and Expression of cDNA Fragments in Escherichia coli, The Journal of Biological Chemistry, vol. 264, No. 19, Issue of Jul. 5, 1989, pp. 11317-11325.
Yen et al, Inhibition of Cholesteryl Ester Transfer Protein Activity by Monoclonal Antibody, J. Clin. Invest., vol. 83, Jun. 1989, pp. 2018-2024.
Lagrost et al, Role of Cholesteryl Ester Transfer Protein (CETP) in the HDL Conversion Process as Evidenced by Using Anti-CETP Monoclonal Antibodies, Journal of Lipid Research, vol. 31, 1990, pp. 1569-1575.
Savolainen et al, Increased High-Density Lipoprotein Cholesterol Concentration in Alcoholics is Related to Low Cholesteryl Ester Transfer Protein Activity, European Journal of Clinical Investigation (1990) 20, pp. 593-599.
Horwitz, Apheresis Adsorbs LDL Only, Medical Tribune, date unknown.
Hafer Robert A.
Rimell Sam
LandOfFree
Method for reducing the risk of atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing the risk of atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing the risk of atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1132669